Acromegaly and mccune-albright syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 6, 2014, Pages 1955-1969

  Salenave, Sylvie ^a   Boyce, Alison M ^b   Collins, Michael T ^c   Chanson, Philippe ^a,d  

^a BICÊTRE HOSPITAL   (France)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ALBRIGHT SYNDROME; ARTICLE; BODY HEIGHT; CAFE AU LAIT SPOT; CANCER RISK; CHONDROSARCOMA; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOFACIAL OSTEOGENIC SARCOMA; DISEASE ASSOCIATION; ENDOCRINE SURGERY; FACE MALFORMATION; FIBROUS DYSPLASIA; GAMMA KNIFE RADIOSURGERY; GIGANTISM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPERPROLACTINEMIA; HYPERTHYROIDISM; HYPOGONADISM; HYPOPHYSIS ADENOMA; LIFE EXPECTANCY; MALIGNANT TRANSFORMATION; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PROGNOSIS; SARCOMA; SHORT STATURE; SYSTEMATIC REVIEW; TOXIC GOITER;

ACROMEGALY; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84902351599     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3826     Document Type: Article

References (120)

1. McCune DJ. Osteitis fibrosa cystica: the case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child. 1936;52: 7 43-747.
2. Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases . N Engl J Med. 1937;216:727-746.
3. McCune DJ, Bruch H. Osteodystrophia fibrosa: report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin and hyp erthyroidism.AmJ Dis Child. 1937;54:806-848.
4. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325:1688-1695.
5. RingelMD,SchwindingerWF,LevineMA.Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary ost eodystrophy. Medicine (Baltimore). 1996;75:171-184.
6. Boyce AM Glover M Kelly MH et al Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone exc ess J Clin Endocrinol Metab. 2013 98 E126-E134.
7. Nerlich A, Peschel O, Lö hrs U, Parsche F, Betz P. Juvenile gigantism plus polyostotic fibrous dysplasia in the Tegernsee giant. Lancet. 1991;338:886-887.
8. Vogl TJ, Nerlich A, Dresel SH, Bergman C. CT of the " Tegernsee Giant" : juvenile gigantism and polyostotic fibrous dysplasia. J Comput Assist Tomogr. 1994;18:319-322.
9. Mogensen EF. Fibrous dysplasia of bone; report of an unusual case with endocrine disorders. Acta Med Scand. 1958;161:453-458.
10. Benedict PH. Endocrine features in Albright's syndrome (fibrous dysplasia of bone). Metabolism. 1962;11:30-45.
11. Wortham JT, Hanblem EC. Polyostotic fibrous dysplasia with sexual precocity and pigmentation (Albright's syndrome) and associated non neoplastic acromegaly. J Clin Endocrinol Metab. 1952; 12:975-976.
12. Scurry MT, Bicknell JM, Fajans SS. Polyostotic fibrous dysplasia and acromegaly. Arch Intern Med. 1964;114:40-45.
13. Vortmeyer AO, Glä sker S, Mehta GU, et al. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome. J C lin Endocrinol Metab. 2012;97:2404-2413.
14. Natarajan MS, Prabhu K, Chacko G, Rajaratnam S, Chacko AG. Endoscopic transsphenoidal excision of a GH-PRL-secreting pituitary macroadenoma in a patie nt with McCune-Albright syndrome. Br J Neurosurg. 2012;26:104-106.
15. Classen CF, Mix M, Kyank U, Hauenstein C, Haffner D. Pamidronic acid and cabergoline as effective long-term therapy in a 12-year-old girl with extended facial polyostotic fibrous dysplasia, prolactinoma and acromegaly in McCune-Albright syndrome: a case report. J Med Case Rep. 2012;6:32.
16. Subbiah S, Palikhe G, Bhadada SK, Mukherjee KK, Bhansali A. Acrogigantism and facial asymmetry: McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2011;24:835-837.
17. Sakayama K, Sugawara Y, Kidani T, et al. Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune-Albright syndrome. Int J Clin Oncol. 2011;16:270-274.
18. Noziè res C, Berlier P, Dupuis C, et al. Spor adic and genetic forms of paediatric somatotropinoma: a retrospective analysis of seven cases and a review of the literature. Orphanet J Rare Dis. 2011; 6:67.
19. Madsen H, Borges MT, Kerr JM, Lilleh ei KO, Kleinschmidt-Demasters BK. McCune-Albright syndrome: surgical and therapeutic challenges in GH-secreting pituitary adenomas. J Neurooncol. 2011;104:215-224.
20. Liu F, Li W, Yao Y, et al. A case of McCune-Albright syndrome associated with pituitary GH adenoma: therapeutic process and autopsy. J Pediatr Endocrinol Metab. 2011;24:283-287.
21. Bhadada SK, Bhansali A, Das S, et al. Fibrous dysplasia & Mc-Cune-Albright syndrome: an experience from a tertiary care centre in north India. Indian J Med Res. 2011;133:504-509.
22. Chakravarty C, Yadav N, Ali Z, Prabhakar H. Upper lip bite test in a patient with McCune Albright syndrome with acromegaly. J Clin Neurosci. 2010;17:258-259.
23. Baszko-Biaszyk D, Slynko J, Liebert W, Sosnowski P, Sowinśki J, Wasḱo R. Difficult ies in diagnosis and treatment of acromegaly in a patient with a McCune-Albright syndrome.Acase report and a review of literature. Neuro Endocrinol Lett. 2010;31: 594-596.
24. Queirolo S, Gallarotti F, Capuan o E, Garrè ML, Spaziante R, Di Battista E. Gigantism with pituitary macroadenoma: an unusual variant of McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2009;22:177-179.
25. Kanazawa I, Yamauchi M, Yano S, et al. Osteosarcoma in a pregnant patient with McCune-Albright syndrome. Bone. 2009;45: 603-608.
26. Almeida JP, Albuquerque LA, Ferraz CL, Mota I, Gondim J, Ferraz TM. McCune-Albright syndrome and acromegaly: hormonal control with use of cabergoline and long-acting somatostatin-case report. Arq Bras Endocrinol Metabol. 2009;53:102-106.
27. Tajima T Tsubaki J Ishizu K Jo W Ishi N Fujieda K Case study of a 15-year-old boy with McCune-Albright syndrome combined with pituitary gigantism: effect of octreotide-long acting release (LAR) and cabergoline t herapy Endocr J.2008 55 595-599.
28. Dou W, Lin N, Ma W, et al. Transsphenoidal surgery in a patient with acromegaly and McCune-Albright syndrome: application of neuronavigation. J Neurosurg. 2008;108:164-169.
29. Zhou J, Sun LH, Cui B, et al. Genetic diagnosis of multiple affected tissues in a patient with McCune-Albright syndrome. Endocrine. 2007;31:212-217.
30. Sung SH, Yoon HD, Shon HS, et al. A case of McCune-Albright syndrome with associated multiple endocrinopathies. Korean J Intern Med. 2007;22:45-50.
31. Ozcan-Kara P, Ma hmoudian B, Erbas B, Erbas T. McCune-Albright syndrome associated with acromegaly and bipolar affective disorder. Eur J Intern Med. 2007;18:600-602.
32. Imanaka M, Iida K, Nishizawa H, et al. McCune-Albright syndrome with acromegaly and fibrous dysplasia associated with the GNAS gene mutation identified by sensitive PNA-clamping method. Intern Med. 2007;46:1577-1583.
33. Sargin H, Gozu H, Bircan R, et al. A case of McCune-Albright syndrome associated with Gs-mutation in the bone tissue. Endocr J. 2006;53:35-44.
34. Papadopoulou M, Doula S, Kitsios K, Kaltsas T, Kosta K. A boy with McCune-Albright syndrome associated with GH secreting pituitary microadenoma. Clinical findings and response to treatment. Hormones (Athens). 2006;5:205-209.
35. Guglani B, Das CJ, Seith A, Tandon N, Loway BA. A deformed skull with enlarging hand and feet in a young female. Br J Radiol. 2006;79:84-86.
36. Galland F, Kamenicky P, Affres H, et al. McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. J Clin Endocrinol Metab. 2006;91:4957-4961.
37. Akintoye SO, Kelly MH, Brillante B, et al. Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. J Clin Endocrinol Metab. 2006;91: 2960-2966.
38. ZacharinM.Paediatric management of endocrine complications in McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2005; 18:33-41.
39. Bhansali A, Sharma BS, Sreenivasulu P, Singh P, VashisthRK,Dash RJ. Acromegaly with fibrous dysplasia: McCune-Albright syndrome-clinical studies in 3 cases and brief review of literature. Endocr J. 2003;50:793-799.
40. Kaushik S, Smoker WR, Frable WJ. Malignant transformation of fibrous dysplasia into chondroblastic osteosarcoma. Skeletal Radiol. 2002;31:103-106.
41. Akintoye SO, Chebli C, Booher S, et al. Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab. 2002;87:5104-5112.
42. Zumkel ler W, Jassoy A, Lebek S, Nagel M. Clinical, endocrinological and radiography features in a child with McCune-Albright syndrome and pituitary adenoma. J Pediatr Endocrinol Metab. 2001;14:553-559.
43. Obuobie K, Mullik V, Jones C, et al. McCune-Albright syndrome: growth hormone dynamics in pregnancy. J Clin Endocrinol Metab. 2001;86:2456-2458.
44. Tinschert S, Gerl H, Gewies A, Jung HP, Nürnberg P. McCune-Albright syndrome: clinical and molecular evidence of mosaicism in an unusual giant patient. Am J Med Genet. 1999;83:100-108.
45. Sakaki S, Yokoyama S, Mamitsuka K, Nakayama M, Goto M, Kuratsu J. A case of pituitary adenoma associated with McCune-Albright syndrome. Pituitary. 1999;1:297-302.
46. Szwajkun P, Chen YR, Yeow VK, Breidahl AF. The " Taiwanese giant" : hormonal and genetic influences in fibrous dysplasia. Ann Plast Surg. 1998;41:75-80.
47. Dö tsch J, Kiess W, Hänze J, et al. Gs-mutation at codon 201 in pituitary adenoma causi ng gigantism in a 6-year-old boy with Mc-Cune-Albright syndrome. J Clin Endocrinol Metab. 1996;81: 3839-3842.
48. Feuillan PP, Jones J, Ross JL. Growth hormone hypersecretion in a girl with McCune-Al bright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab. 1995;80:1357-1360.
49. Gessl A Freissmuth M Czech T et al Growth hormon e-prolactinthyrotropin- secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs-protein J Clin Endocrinol Metab. 1994 79 1128-1134.
50. Garcia MB, Koppeschaar HP, Lips CJ, Thijssen JH, Krenning EP. Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with the somatostatin analogue octreotide. J Endocrinol Invest. 1994; 17:59-65.
51. Chanson P, Dib A, Visot A, Derome PJ. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Eur J Endocrinol. 1994;131:229-234.
52. Sherman SI, Ladenson PW. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. J Endocrinol Invest. 1992;15:185-190.
53. Premawardhana LD, Vora JP, Mills R, Scanlon MF. Acromegaly and its treatment in the McCune-Albright syndrome. Clin Endocrinol (Oxf). 1992;36:605-608.
54. Cremonini N, Graz iano E, Chiarini V, Sforza A, Zampa GA. Atypical McCune-Albright syndrome associated with growth hormoneprolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995-bromocriptine combined treatment results. J Cl in Endocrinol Metab. 1992;75:1166-1169.
55. Kupcha PC, Guille JT, Tassanawipas A, Bowen JR. Polyostotic fibrous dysplasia and acromegaly. J Pediatr Orthop. 1991;11: 95-99.
56. Swislocki AL, Camargo CA, Hoffman AR. McCune-Albright syndrome. A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadism. West J Med. 1990; 153:653-656.
57. Huang TS, Chang CC, Huang JS, Hsieh HC, Chen FW. Albright's syndrome with acromegaly and Hashimoto's thyroiditis: report of a case. J Formos Med Assoc. 1990;89:714-718.
58. Abs R, Beckers A, Van de Vyver FL, De Schepper A, Stevenaert A, Hennen G. Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome. J Endocrinol Invest. 1990;13:671-675.
59. Pun KK, Chan G, Kung A, Lam K, Chan FL, Wang C. McCune-Albright syndrome with acromegaly. Horm Metab Res. 1989;21: 527-528.
60. O'Laughlin RL, Selinger SE, Moriarty PE. Pituitary adenoma in McCune-Albright syndrome:MRdemonstration. J Comput Assist Tomogr. 1989;13:685-688.
61. Mortensen A, Bojsen-Mø ller M, Rasmussen P. Fibrous dysplasia of the skull with acromegaly and sarcomatous transformation. Two cases with a review of the literature. J Neurooncol. 1989;7:25-29.
62. Cuttler L, Jackson JA, Saeed uz-Zafar M, Levitsky LL, Mellinge r RC, Frohman LA. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab. 1989;68:1148-1154.
63. Misaki M, Shima T, Ikoma J, Morioka K, Suzuki S. Acromegaly and hyperthyroidism associated with McCune-Albright syndrome. Horm Res. 1988;30:26-27.
64. Pacini F, Perri G, Bagnolesi P, Cilotti A, Pinchera A. McCune-Albright syndrome with gigantism and hyperprolactinemia. J Endocrinol Invest. 1987;10:417-420.
65. Kumawat DC, Bomb BS, Agarwal HK, Bhatnagar HN. The Albright syndrome associated with acromegaly and hyperthyroidism (a case report). J Postgrad Med. 1987;33:155-157.
66. Geffner ME, Nagel RA, Dietrich RB, Kaplan SA. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. J Pediatr. 1987;111:740-743.
67. Present D, Bertoni F, Enneking WF. Osteosarcoma of the mandible arising in fibrous dysplasia. A case report. Clin Orthop Relat Res. 1986;204:238-244.
68. Mauras N, Blizzard RM. The McCune-Albright syndrome. Acta Endocrinol Suppl (Copenh). 1986;279:207-217.
69. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome. Long-term follow-up. JAMA. 1986;256:2980-2984.
70. Nakagawa H Nagasaka A Sugiura T et al Gigantism associated with McCune-Albright's syndrome Horm Metab Res. 1985 17 522-527.
71. Harris RI. Polyostotic fibrous dysplasia with acromegaly. Am J Med. 1985;78:539-542.
72. Kovacs K, Horvath E, Thorner MO, Rogol AD. Mammosomatotroph hyperplasia associa ted with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis. Virchows Arch A Pathol Anat Histopathol. 1984;403:77-86.
73. Chung KF, Alaghband-Zadeh J, Guz A. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction. Am J Dis Child. 1983;137:134-136.
74. Polychronakos C, Tsoukas G, Ducharme JR, Letarte J, Collu R. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (McCune-Albright syndrome). J Endocrinol Invest. 1982;5:323-326.
75. Lipson A, Hsu TH. The Albright syndrome associated with acromegaly: report of a case and review of the literature. Johns Hopkins Med J. 1981;149:10-14.
76. Albin J, Wu R . Abnormal hypothalamic-pituitary function in polyostotic fibrous dysplasia. Clin Endocrinol (Oxf). 1981;14: 435-443.
77. Carr D, Mathie IK, Manners AR, Colman C. Hyperprolactinaemia in a patient with the McCune-Albright syndrome. Br J Obstet Gynaecol. 1979;86:330-331.
78. Powell DG. Polyostotic fibrous dysplasia with acromegaly (Albright's syndrome). A case report. S Afr Med J. 1976;50:182-183.
79. Joishy SK, Morrow LB. McCune-Albright syndrome associated with a functioning pituitary chromophobe adenoma. J Pediatr. 1976;89:73-75.
80. Lightner ES, Penny R, Frasier SD. Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): evidence for abnormal hypothalamic function. J Pediatr. 1975;87:922-927.
81. Brockmann H, Joe A, Palmedo H, Biersack HJ. A patient with acromegaly presenting with polyostotic fibrous dysplasia on bone scan: McCune-Albright syndrome. Clin Nucl Med. 2005;30:813-815.
82. Chen CJ, Liu JY, Cheng SN, ChangFW,YuhYS. McCune-Albright syndrome associated with pituitary microadenoma: patient report. J Pediatr Endocrinol Metab. 2004;17:365-369.
83. Richar ds PS, King AD. A case of big bad bones. Br J Radiol. 2003; 76:503-504.
84. Blanco P, Schaeverbeke T, Baillet L, Lequen L, Bannwarth B, Dehais J. Chondrosarcoma in a patient with McCune-Albright syndrome. Report of a case. Rev Rhum Engl Ed. 1999;66:177-179.
85. Hall MB, Sclar AG, Gardner DF. Albright's syndrome with reactivation of fibrous dysplasia secondary to pituitary adenoma and further complicated by osteogenic sarcoma. Report of a case. Oral Surg Oral Med Oral Pathol. 1984;57:616-619.
86. Hansen MR, Moffat JC. Osteosarcoma of the skull base after radiation therapy in a patient with McCune-Albright syndrome: case report. Skull Base. 2003;13:79-83.
87. Heller AJ, DiNardo LJ, Massey D. Fibrous dysplasia, chondrosarcoma, and McCune-Albright syndrome. Am J Otolaryngol. 2001; 22:297-301.
88. Moran A, Asa SL, Kovacs K, et al. Gigantism due to pituitary mammosomatotroph hyperplasia. N Engl J Med. 1990;323:322-327.
89. Chanson P, S alenave S, Kamenicky P, Cazabat L,YoungJ. Pituitary tumours: acromegaly. Best Pract Res Clin Endocrinol Metab. 2009;23:555-574.
90. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006; 355:2558-2573.
91. Mastorakos G Mitsiades NS Doufas AG Koutras DA Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report Thy roid. 1997 7 433-439.
92. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004;25:102-152.
93. Brown RJ, Kelly MH, Collins MT. Cushing syndrome in the Mc-Cune-Albright syndrome. J Clin Endocrinol Metab. 2010;95: 1508-1515.
94. Lisle DA, Monsour PA, Maskiel l CD. Imaging of craniofacial fibrous dysplasia. J Med Imaging Radiat Oncol. 2008;52:325-332.
95. Cutler CM, Lee JS, Butman JA, et al. Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery. 2006;59:1011-1017; discussion 1017-1018.
96. Lee JS, FitzGibbon E, Butman JA, et al. Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med. 2002;347:1670-1676.
97. Uwaifo GI, Robey PG, Akintoye SO, Collins MT. Clinical picture: fuel on the fire. Lancet. 2001;357:2011.
98. Collins MT, Singer FR, Eugster E. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis. 2012;7(suppl 1):S4.
99. Shenker A, Weinstein LS, Moran A, et al. Severe endocrine and n onendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993;123:509-518.
100. Chanson P, Kamenicky P. Treatment of acromegaly: a critical analysis of the last ten years [in French]. Ann Endocrinol (Paris). 2012; 73:99-106.
101. Jane JA Jr, Starke RM, Elzoghby MA, et al. Endoscopic transsphenoidal surgery for acrome galy: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab. 2011;96:2732-2740.
102. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. Eur J Endocrinol. 2005;152:379-387.
103. MercadoM,Borges F, Bouterfa H, et al.Aprospective, multicentre study to investigate the eff icacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly. Clin Endocrinol (Oxf). 2007; 66:859-868.
104. Carmichael JD, Bonert VS. Medical therapy: options and uses. Rev Endocr Metab Disord. 2008;9:71-81.
105. Neggers SJ, van der Lely AJ. Somatostatin analog and pegvisomant combination therapy for acromegaly. Nat Rev Endocrinol. 2009; 5:546-552.
106. Bell WH, Hinds EC. Fibrosarcoma complicating polyostotic fibrous dysplasia. Oral Surg Oral Med Oral Pathol. 1967;23:299-310
107. de Araújo PI, Soares VY, Queiroz AL, dos SantosAM,Nascimento LA. Sarcomatous transformation in the McCune-Albright syndrome. Oral Maxillofac Surg. 2012;16:217-220.
108. Dustin P Jr, LeyRA.Contribution to the study of oss eous dysplasia: anatomico-clinical description of a case of polymorphous osteosarcoma in a child with osseous fibroxanthoma and sexual prematurity[ in undetermined language]. Rev Belg Pathol Med Exp. 1950;20:52-72.
109. Jhala DN, Eltoum I, Carroll AJ, et al. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: a case report emphasizing the cytological and cytogenetic findings. Hum Pathol. 2003;34:1354-1357.
110. Lopez-Ben R, Pitt MJ, Jaffe KA, Siegal GP. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome. Skeletal Radiol. 1999;28:522-526.
111. Ozaki T, Lindner N, Blasius S. Dedifferentiated chondrosarcoma in Albright syndrome. A case report and review of the literature. J Bone Joint Surg Am. 1997;79:1545-1551.
112. Parr ini L. The malignant transformation of fibrous dysplasia. Chirurgica. 1957;12:3-11.
113. Pons A Arlet J Alibelli MJ Fabie M Fabre J Malignant degeneration of fibrous bone dysplasia: general review apropos of 2 cases [in French] Ann Radiol (Paris). 1974 17 713-720.
114. Roze R, Mazabraud A, Semat P. [Fibrous dysplasia of bone and myxomas of the soft tissues. Localized sarcomatous de generation [in French]. J Radiol Electrol Med Nucl. 1967;48:527-536.
115. Ruggieri P, Sim FH, Bond JR, Unni KK. Osteosarcoma in a patient with polyostotic fibrous dysplasia and Albright's syndrom e. Orthopedics. 1995;18:71-75.
116. Snapper L. Medical Clinics on Bone Disease, a Text and Atlas. 2nd ed. New York: Interscience Publishers Inc; 1949.
117. Schwartz DT, Alpert M. The malignant transformation of fibrous dysplasia. Am J Med Sci. 1964;247:1-20.
118. Collins MT, Sarlis NJ, Merino MJ, et al. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs-mutations. J Clin Endocrinol Metab. 2003;88:4413-4417.
119. Gaujoux S, Salenave S, Ronot M, et al. Hepatobiliary and pancreatic neoplasms in patients with McCune-Albright syndrome. J Clin Endocrinol Metab. 2014;99:E97-E101.
120. Lightner ES, Penny R, Frasier SD. Letter: pituitary adenoma in McCune-Albright syndrome: follow-up information. J Pediatr. 1976;89:159.